Cantitate/Preț
Produs

Hepatitis B Research Advances

Editat de Alicia P. Willis
en Limba Engleză Hardback – 19 feb 2007
Hepatitis B is a disease of the liver caused by the Hepatitis B virus (HBV), a member of the Hepadnavirus family and one of several unrelated viral species which cause viral hepatitis. It was originally known as "serum hepatitis" and has caused current epidemics in parts of Asia and Africa. Hepatitis B is recognised as endemic in China and various other parts of Asia. The proportion of the world's population currently infected with the virus is 3 to 6%, but up to a third have been exposed. Symptoms of the acute illness caused by the virus include liver inflammation, vomiting, jaundice, and rarely, death. Chronic hepatitis B may cause liver cirrhosis which may then lead to liver cancer. This book presents the latest advances in the field.
Citește tot Restrânge

Preț: 130428 lei

Preț vechi: 178674 lei
-27% Nou

Puncte Express: 1956

Preț estimativ în valută:
24969 25992$ 20556£

Carte disponibilă

Livrare economică 11-25 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781600216664
ISBN-10: 1600216668
Pagini: 312
Ilustrații: tables & charts
Dimensiuni: 183 x 268 x 24 mm
Greutate: 0.88 kg
Editura: Nova Science Publishers Inc

Cuprins

Preface; Birth Dose of Hepatitis B Vaccine; How Methods of Administration Affect Presentation; Revisiting the Monotherapy with Antiviral Drug in Patients with Chronic Hepatitis B: Ethical and Scientific Basis of Combination Therapy and their Application in Clinics; Recent Topics for Hepatitis B Vaccination; A Comparative Evaluation of Latex Agglutination, Immunochromatographic Strip, and ELISA Techniques in the Seroepdemiological Survey of Hepatitis-B Surface Antigen among Blood Donors in South; Hepatitis B Virus and others Blood-Borne Viral Hepatitis Infections among Drug Users. The Role of Vaccination; Immunotherapeutic Efficacy of DNA Vaccine alone and combined with Antiviral Drugs in the Chronic; Risk Factors of Hepatitis B Virus in Sub-Urban and Rural Areas of Nigeria; Roles Of Hepatitis B Virus In Hepatocarcinogenesis; Hepatitis B Viral Factors Affecting Long-Term Outcomes of Chronic Hepatitis B; Surveillance and Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B; Treatment Approaches for Chronic Hepatitis B with Respect to the Natural History of HBV Virus; Prophylaxis of Recurrent Hepatitis B after Liver Transplantation; Hepatitis B Virus Mutants and their Clinical Implications; Protective Effect of Alpha-Tocopherol (Vitamin E) in Head and Neck Cancer; Essential Immune Responses to Hepatitis B Virus Infection; Index.